{"AllianceGenome": "4235", "HGNC": "4235", "MIM": "137780", "_id": "2670", "_version": 3, "accession": {"genomic": ["AC015936.14", "AY142187.1", "AY142188.1", "AY142191.1", "CH471178.2", "CP068261.2", "CS088769.1", "LC214884.1", "M67446.1", "NC_000017.11", "NC_060941.1", "NG_008401.2"], "protein": ["AAA52528.1", "AAA52529.1", "AAB22581.1", "AAH13596.1", "AAH41765.1", "AAH62609.1", "AAI27872.1", "AAL16662.1", "AAN87903.1", "AAN87904.1", "AAN87907.1", "ABL14186.1", "BAC87610.1", "BAD96403.1", "BAG37791.1", "BAG58573.1", "BAG58972.1", "BAG64704.1", "BBA18129.1", "CAB61354.2", "CAC69881.1", "CAI99149.1", "EAW51567.1", "EAW51568.1", "EAW51569.1", "EAW51570.1", "EAW51571.1", "NP_001124491.1", "NP_001229305.1", "NP_001350775.1", "NP_002046.1", "P14136.1"], "rna": ["AF131813.1", "AF419299.1", "AJ306447.1", "AK098380.1", "AK098758.1", "AK124465.1", "AK128790.1", "AK222683.1", "AK295734.1", "AK296259.1", "AK303728.1", "AK315398.1", "AL133013.1", "BC012228.1", "BC013596.1", "BC041765.1", "BC062609.1", "BC127871.1", "BF341765.1", "BF526347.1", "BM687259.1", "BM931499.1", "DA254392.1", "DA315956.1", "DQ979832.1", "J04569.1", "M26638.1", "NM_001131019.3", "NM_001242376.3", "NM_001363846.2", "NM_002055.5", "S40719.1", "U92979.1"], "translation": [{"protein": "AAI27872.1", "rna": "BC127871.1"}, {"protein": "AAA52528.1", "rna": "J04569.1"}, {"protein": "CAC69881.1", "rna": "AJ306447.1"}, {"protein": "AAH41765.1", "rna": "BC041765.1"}, {"protein": "BAC87610.1", "rna": "AK128790.1"}, {"protein": "NP_001350775.1", "rna": "NM_001363846.2"}, {"protein": "BAG58573.1", "rna": "AK295734.1"}, {"protein": "ABL14186.1", "rna": "DQ979832.1"}, {"protein": "AAA52529.1", "rna": "M26638.1"}, {"protein": "AAH13596.1", "rna": "BC013596.1"}, {"protein": "AAL16662.1", "rna": "AF419299.1"}, {"protein": "BAG64704.1", "rna": "AK303728.1"}, {"protein": "AAB22581.1", "rna": "S40719.1"}, {"protein": "NP_001229305.1", "rna": "NM_001242376.3"}, {"protein": "CAB61354.2", "rna": "AL133013.1"}, {"protein": "NP_001124491.1", "rna": "NM_001131019.3"}, {"protein": "BAG58972.1", "rna": "AK296259.1"}, {"protein": "BAG37791.1", "rna": "AK315398.1"}, {"protein": "NP_002046.1", "rna": "NM_002055.5"}, {"protein": "AAH62609.1", "rna": "BC062609.1"}, {"protein": "BAD96403.1", "rna": "AK222683.1"}]}, "alias": "ALXDRD", "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2024-01-10T17:00:00.000Z", "disease_label": "Alexander disease", "gcep": "Leukodystrophy and Leukoencephalopathy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0008752", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1da6d658-360e-4097-95a9-0b6838638e31-2024-01-10T170000.000Z", "sop": "SOP10"}}, "ensembl": {"gene": "ENSG00000131095", "protein": ["ENSP00000253408", "ENSP00000366189", "ENSP00000403962", "ENSP00000465208", "ENSP00000465320", "ENSP00000465565", "ENSP00000465629", "ENSP00000466163", "ENSP00000466598", "ENSP00000467106", "ENSP00000467397", "ENSP00000467530", "ENSP00000468500", "ENSP00000491042", "ENSP00000491088", "ENSP00000491243", "ENSP00000491375", "ENSP00000491466", "ENSP00000491735", "ENSP00000492156", "ENSP00000492300", "ENSP00000492432", "ENSP00000492832", "ENSP00000492860"], "transcript": ["ENST00000253408", "ENST00000376990", "ENST00000435360", "ENST00000441312", "ENST00000585543", "ENST00000585728", "ENST00000586125", "ENST00000586127", "ENST00000586793", "ENST00000587997", "ENST00000588037", "ENST00000588316", "ENST00000588640", "ENST00000588735", "ENST00000588957", "ENST00000589701", "ENST00000590922", "ENST00000591327", "ENST00000591719", "ENST00000591880", "ENST00000592065", "ENST00000592320", "ENST00000592706", "ENST00000593179", "ENST00000638281", "ENST00000638304", "ENST00000638400", "ENST00000638488", "ENST00000638618", "ENST00000638921", "ENST00000639042", "ENST00000639243", "ENST00000639277", "ENST00000639369", "ENST00000639921", "ENST00000640545", "ENST00000640552", "ENST00000640859"], "translation": [{"protein": "ENSP00000466598", "rna": "ENST00000588735"}, {"protein": "ENSP00000492432", "rna": "ENST00000639277"}, {"protein": "ENSP00000491042", "rna": "ENST00000638304"}, {"protein": "ENSP00000491375", "rna": "ENST00000639243"}, {"protein": "ENSP00000491243", "rna": "ENST00000639369"}, {"protein": "ENSP00000492300", "rna": "ENST00000640859"}, {"protein": "ENSP00000491466", "rna": "ENST00000638400"}, {"protein": "ENSP00000492860", "rna": "ENST00000639042"}, {"protein": "ENSP00000491735", "rna": "ENST00000640545"}, {"protein": "ENSP00000253408", "rna": "ENST00000253408"}, {"protein": "ENSP00000467397", "rna": "ENST00000586125"}, {"protein": "ENSP00000492832", "rna": "ENST00000638618"}, {"protein": "ENSP00000467530", "rna": "ENST00000591880"}, {"protein": "ENSP00000403962", "rna": "ENST00000435360"}, {"protein": "ENSP00000491088", "rna": "ENST00000638281"}, {"protein": "ENSP00000492156", "rna": "ENST00000639921"}, {"protein": "ENSP00000465320", "rna": "ENST00000592320"}, {"protein": "ENSP00000468500", "rna": "ENST00000586793"}, {"protein": "ENSP00000366189", "rna": "ENST00000376990"}, {"protein": "ENSP00000465565", "rna": "ENST00000588957"}, {"protein": "ENSP00000465629", "rna": "ENST00000588316"}, {"protein": "ENSP00000465208", "rna": "ENST00000585728"}, {"protein": "ENSP00000466163", "rna": "ENST00000588037"}, {"protein": "ENSP00000467106", "rna": "ENST00000593179"}], "type_of_gene": "protein_coding"}, "entrezgene": "2670", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 13.1595470365, "exp_mis": 195.10135757, "exp_syn": 83.6167059093, "lof_z": 1.13583499851814, "mis_z": 1.47428958123397, "mu_lof": 1.1007683694e-06, "mu_mis": 1.87506761641e-05, "mu_syn": 7.95285210729e-06, "n_lof": 9.0, "n_mis": 153.0, "n_syn": 59.0, "p_li": 2.22936756487388e-05, "p_null": 0.27036854833762, "p_rec": 0.729609157986731, "syn_z": 1.66891007608956}, "bp": 1317, "cds_end": 42992854, "cds_start": 42987836, "n_exons": 7, "nonpsych": {"exp_lof": 11.7893692279, "exp_mis": 176.464270165, "exp_syn": 75.5599044125, "lof_z": 1.65591468383771, "mis_z": 1.34655671594514, "mu_lof": 1.1007683694e-06, "mu_mis": 1.87506761641e-05, "mu_syn": 7.95285210729e-06, "n_lof": 6.0, "n_mis": 141.0, "n_syn": 54.0, "p_li": 0.00273288079792492, "p_null": 0.0713342383478239, "p_rec": 0.925932880854251, "syn_z": 1.56158117744521}, "nontcga": {"exp_lof": 12.0949611134, "exp_mis": 179.481439658, "exp_syn": 76.9155578172, "lof_z": 0.87787810280581, "mis_z": 1.35666310469647, "mu_lof": 1.1007683694e-06, "mu_mis": 1.87506761641e-05, "mu_syn": 7.95285210729e-06, "n_lof": 9.0, "n_mis": 143.0, "n_syn": 50.0, "p_li": 1.3211159900892e-05, "p_null": 0.381876941355881, "p_rec": 0.618109847484218, "syn_z": 1.94320496109179}, "transcript": "ENST00000586793.1"}, "exons": [{"cdsend": 44915486, "cdsstart": 44910135, "chr": "17", "position": [[44909672, 44910260], [44910614, 44910658], [44911235, 44911456], [44911671, 44911797], [44913268, 44913430], [44913727, 44913823], [44914027, 44914088], [44915025, 44915500]], "strand": -1, "transcript": "NM_001131019", "txend": 44915500, "txstart": 44909672}, {"cdsend": 44915486, "cdsstart": 44910468, "chr": "17", "position": [[44909672, 44910658], [44911235, 44911456], [44911671, 44911797], [44913268, 44913430], [44913727, 44913823], [44914027, 44914088], [44915025, 44915500]], "strand": -1, "transcript": "NM_001242376", "txend": 44915500, "txstart": 44909672}, {"cdsend": 44915486, "cdsstart": 44907346, "chr": "17", "position": [[44905625, 44907388], [44908063, 44908149], [44910140, 44910260], [44910614, 44910658], [44911235, 44911456], [44911671, 44911797], [44913268, 44913430], [44913727, 44913823], [44914027, 44914088], [44915025, 44915500]], "strand": -1, "transcript": "NM_001363846", "txend": 44915500, "txstart": 44905625}, {"cdsend": 44915486, "cdsstart": 44907346, "chr": "17", "position": [[44903158, 44907388], [44908063, 44908149], [44910614, 44910658], [44911235, 44911456], [44911671, 44911797], [44913268, 44913430], [44913727, 44913823], [44914027, 44914088], [44915025, 44915500]], "strand": -1, "transcript": "NM_002055", "txend": 44915500, "txstart": 44903158}], "exons_hg19": [{"cdsend": 42992854, "cdsstart": 42987503, "chr": "17", "position": [[42987040, 42987628], [42987982, 42988026], [42988603, 42988824], [42989039, 42989165], [42990636, 42990798], [42991095, 42991191], [42991395, 42991456], [42992393, 42992868]], "strand": -1, "transcript": "NM_001131019", "txend": 42992868, "txstart": 42987040}, {"cdsend": 42992854, "cdsstart": 42987836, "chr": "17", "position": [[42987040, 42988026], [42988603, 42988824], [42989039, 42989165], [42990636, 42990798], [42991095, 42991191], [42991395, 42991456], [42992393, 42992868]], "strand": -1, "transcript": "NM_001242376", "txend": 42992868, "txstart": 42987040}, {"cdsend": 42992854, "cdsstart": 42984714, "chr": "17", "position": [[42982993, 42984756], [42985431, 42985517], [42987508, 42987628], [42987982, 42988026], [42988603, 42988824], [42989039, 42989165], [42990636, 42990798], [42991095, 42991191], [42991395, 42991456], [42992393, 42992868]], "strand": -1, "transcript": "NM_001363846", "txend": 42992868, "txstart": 42982993}, {"cdsend": 42992854, "cdsstart": 42984714, "chr": "17", "position": [[42980526, 42984756], [42985431, 42985517], [42987982, 42988026], [42988603, 42988824], [42989039, 42989165], [42990636, 42990798], [42991095, 42991191], [42991395, 42991456], [42992393, 42992868]], "strand": -1, "transcript": "NM_002055", "txend": 42992868, "txstart": 42980526}], "generif": [{"pubmed": 11567214, "text": "spectrum of GFAP mutations and genotype-phenotype correlation in infantile Alexander disease"}, {"pubmed": 11587071, "text": "The GFAP gene of a Japanese girl who presented with typical symptoms of Alexander disease but in whom the diagnosis was not proven by histopathology was sequenced. A missense mutation, R239C was identified."}, {"pubmed": 11867077, "text": "a new heterozygous amino acid substitution, Val87Gly in exon 1 of GFAP, in palatal myoclonus, pyramidal tract signs, cerebellar signs, marked atrophy of the medulla oblongata and spinal cord, and autosomal dominant inheritance."}, {"pubmed": 12034796, "text": "A disease-causing mutation (E362D) has been found in the GFAP protein of a 13-year-old boy with juvenile Alexander disease which characterizes the late-onset, milder form of this disease compared to the severe type."}, {"pubmed": 12058025, "text": "interaction with presenilin 1 and 2"}, {"pubmed": 12084347, "text": "GFAP expression correlates with cytoplasmic expression of wild-type p53 in human primary glioblastoma."}, {"pubmed": 12169273, "text": "Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity."}, {"pubmed": 12447932, "text": "The first report of identification of the causative mutation of the GFAP gene for neuropathologically proven hereditary adult-onset Alexander's disease suggests a common molecular mechanism underlying the three Alexander's disease subtypes."}, {"pubmed": 12581808, "text": "Alternation of arginine residue can give GFAP protein a dominant negative effect, leading to accumulation of GFAP as Rosenthal fibers. Alexander disease novel mutation R79L in Japanese patient."}, {"pubmed": 12884016, "text": "significantly elevated in the CSF of neurocysticercosis patients compared with the control"}, {"pubmed": 12931206, "text": "Novel GFAP splice forms Delta 135 nt, Delta exon 6 and Delta 164 nt were identified. Neuronal GFAP is observed in the hippocampal pyramidal cells of Alzheimer and Down syndrome patients and aged controls, but not hippocampal sclerosis patients."}, {"pubmed": 14557587, "text": "A heterozygous T to C transition at nucleotide 1055 of the GFAP gene resulting in an amino acid replacement of leucine by proline at codon 352 (L352P) was noted in an infant with Alexander disease"}, {"pubmed": 15238995, "text": "A decrease in levels of GFAP in the dorsolateral prefrontal cortex may contribute to the pathophysiology of major depressive disorder, particularly in subjects of relatively young age."}, {"pubmed": 15284230, "text": "the GFAPepsilon tail prevents GFAPepsilon homodimerization and homomeric filament formation, whereas the ability to form heterodimers and filaments with GFAPalpha is retained"}, {"pubmed": 15465095, "text": "Molecular analysis showed that the patient of alexander's disease was a heterozygote of the L331P mutation of GFAP."}, {"pubmed": 15469203, "text": "Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression."}, {"pubmed": 15477559, "text": "We present a case that suggests a relationship between mitochondrial abnormality and Alexander disease with GFAP mutation."}, {"pubmed": 15732097, "text": "Dominant missense glial fibrillary acidic protein mutations account for nearly all forms of Alexander disease."}, {"pubmed": 15837555, "text": "Perinuclear collapse of the intermediate filament GFAP is demonstrated in primary schwannoma cells, which become motile, unspecifically ensheathing the extracellular matrix and forming pseudomesaxons."}, {"pubmed": 15885920, "text": "This study found higher levels of GFAP mRNA in white matter and at the pial surface as compared with gray matter levels in all cases of depression, bipolar disorder and schizophrenia."}, {"pubmed": 15979880, "text": "A 60% increase in acidic isoforms of GFAP occurred in AD; these isoforms were both phosphorylated and N-glycosylated, while more basic isoforms were O-glycosylated and exhibited no differences between post-mortem AD and control brains."}, {"pubmed": 16147953, "text": "Increased GFAP levels in autistic brains signify gliosis, reactive injury, and perturbed neuronal migration processes."}, {"pubmed": 16168593, "text": "In a 6-year-old patient with a relatively mild form of Alexander disease, we detected a common R79H mutation in GFAP."}, {"pubmed": 16168595, "text": "The genetic analysis revealed a new missense mutation, an A to G transition at nucleotide position 1026 in exon 6, leading to the substitution of glycine for glutamic acid at amino acid position 371(E371G)."}, {"pubmed": 16217707, "text": "GFAP levels in the CSF were highly elevated in three genetically confirmed cases of Alexander disease clinically conforming with infantile, early and late juvenile forms."}, {"pubmed": 16303762, "text": "AP-1 is a key transcription factor that, in part, controls astrocyte-specific expression of genes including the ACT and GFAP genes"}, {"pubmed": 16365790, "text": "Intravitreal administration of NMDA caused a significant decrease in the thickness of the retinal layers and induced upregulation of glial fibrillary acidic protein (GFAP)."}, {"pubmed": 16458536, "text": "Data show that glial fibrillary acidic protein-positive progenitor cells give rise to neurons and oligodendrocytes throughout the central nervous system."}, {"pubmed": 16507904, "text": "Co-localization, co-immunoprecipitation, and in vitro overlay analyses demonstrated direct interaction of plectin and GFAP."}, {"pubmed": 16507909, "text": "These data suggest that the activation of caspases and cleavage of cellular proteins such as GFAP may contribute to astrocyte injury and damage in the Alzheimer's disease brain."}, {"pubmed": 16565071, "text": "NFI-X cooperates with (activator protein 1)AP-1 by an unknown mechanism in astrocytes, which results in the expression of a subset of astrocyte-specific genes."}, {"pubmed": 16773221, "text": "GFAP was strong expression in both reactive astrocytes and astrocytomas. Expression of both GFAP is more focal in oligodendrogliomas, with staining of mainly intervening astrocytic processes."}, {"pubmed": 16826512, "text": "The presence of glial fibrillary acidic protein mutant, R416W, is the characteristic histopathological feature of Alexander disease: a component of Rosenthal fibers."}, {"pubmed": 16866629, "text": "Cerebrospinal fluid GFAP levels are of prognostic value in patients with subarachnoid hemorrhage."}, {"pubmed": 17008879, "text": "analysis of glial fibrillary acidic protein, metallothionein, and MHC II expression in human, rat and mouse cells"}, {"pubmed": 17203480, "text": "Isolation of an evolutionary conserved novel GFAP isoform, GFAPkappa, produced by alternative splicing and polyadenylation of the 3'-region of the human GFAP pre-mRNA is described."}, {"pubmed": 17318298, "text": "These findings suggest that the functional abnormalities of astrocytes might be induced prior to aggregation of GFAP in Alexander disease and that the functional alteration depends on the location of the domain."}, {"pubmed": 17515952, "text": "GFAP was differentially expressed in sclerotic hippocampi compared to non-sclerotic ones."}, {"pubmed": 17601350, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17703343, "text": "A c1178G>T mutation was detected in the GFAP gene of a 35 year old female patient diagnosed with Alexander disease and also in her affected 6 year old son."}, {"pubmed": 17805552, "text": "Here we report a case of Alexander disease with occipital predominance and a novel c.799G>C mutation in the GFAP gene."}, {"pubmed": 17894839, "text": "GFAP mutations and polymorphisms in 13 unrelated Italian patients affected by Alexander disease."}, {"pubmed": 17934883, "text": "An adult form of Alexander disease: a novel mutation(M74T amino acid change) in glial fibrillary acidic protein"}, {"pubmed": 17981838, "text": "Data suggest a model with the selection of the exon 7a polyadenylation site being the essential and primary event for regulating GFAP alternative processing."}, {"pubmed": 17985264, "text": "Novel mutations in exon 6 of the GFAP gene affect a highly conserved if motif in the rod domain 2B and are associated with early onset infantile Alexander disease."}, {"pubmed": 18004641, "text": "Here we describe four members of an Italian family affected by adult Alexander disease. Two novel GFAP missense mutations were found involving two very close codons, c.[988C > G, 994G > A], leading to p.[Arg330Gly, Glu332Lys]."}, {"pubmed": 18054694, "text": "This is the first report of a novel deletion mutation in the glial fibrillary acidic protein gene with a frame shift associated with Alexander disease."}, {"pubmed": 18079314, "text": "A novel mutation, Y83H, and a previously reported mutation, R88C, were identified in 3 cases with the infantile or juvenile form of Alexander disease."}, {"pubmed": 18197187, "text": "Identification of two GFAP mutations, coupled on a same allele. Functional studies on this allele revealed less severe aggregation patterns compared to those observed with p.R239C GFAP mutant, associated with a severe Alexander disease phenotype."}, {"pubmed": 18276609, "text": "Alexander disease mutant GFAP accumulation stimulates autophagy, in a manner regulated by p38 MAPK and mTOR signaling pathways."}, {"pubmed": 18508349, "text": "GFAP levels may be used in Guillain-Barre syndrome as a diagnostic marker of the axonal variant and to predict outcome"}, {"pubmed": 18685083, "text": "Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association"}, {"pubmed": 18977241, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19034380, "text": "This protein has been found differentially expressed in the temporal lobe from patients with schizophrenia."}, {"pubmed": 19110265, "text": "This protein has been found differentially expressed in the dorsolateral prefrontal cortex from patients with schizophrenia."}, {"pubmed": 19129171, "text": "In Alexander disease mouse models that loss of Cryab results in increased mortality, whereas elevation of Cryab rescues animals from terminal seizures."}, {"pubmed": 19170683, "text": "GFAP is immunolocalized regionally within cells and tumors of astrocytic origin and suggest that their binding may occur during dynamic reorganization of intermediate filaments"}, {"pubmed": 19221847, "text": "Data show tha GFAP levels are significantly higher in intracerebral hemorrhage patients than in ischemic stroke patients."}, {"pubmed": 19264642, "text": "Downregulated by cytomegalovirus IE1 and IE2 proteins during HCMV infection in U373MG cell line."}, {"pubmed": 19283393, "text": "EAAT-1 is superior to GFAP as a helpful diagnostic tool for cancer in choroid plexus samples"}, {"pubmed": 19372295, "text": "There were strong correlations between the cerebrospinal fluid glial fibrillar acidic protein level and expanded disability status scales or spinal lesion length in neuromyelitis optica"}, {"pubmed": 19379794, "text": "This study indicates that the mechanism of GFAP aggregation depends on the domain in which the point mutation(R239C and R416W) is located."}, {"pubmed": 19405953, "text": "This protein has been found differentially expressed in the Wernicke's Area from patients with schizophrenia."}, {"pubmed": 19420941, "text": "Population variation in GFAP with varying Alzheimer lesion burdens suggests that they are not the only driver for astrogliosis"}, {"pubmed": 19444543, "text": "our cell transfection data do indicate that the p.Glu223Gln change has an effect on GFAP polymerization, albeit a modest one"}, {"pubmed": 19447584, "text": "GFAP had higher mean expression levels across regions in all psychiatric groups relative to normal control."}, {"pubmed": 19508443, "text": "GFAP-delta is expressed in a variety of pathologies associated with epilepsy, increased expression is shown in regions of astrocytic gliosis"}, {"pubmed": 19521276, "text": "the best immunohistochemical markers useful for the evaluation of tumors with chordoid morphology were D2-40, EMA, cytokeratin, and GFAP. D2-40 was a true chondroid marker to be useful for the differential diagnosis with chordoma"}, {"pubmed": 19540848, "text": "NFI family of transcription factors plays a key role in the regulation of both the B-FABP and GFAP genes in malignant glioma cells."}, {"pubmed": 19618846, "text": "Novel variant (S398F) in the glial fibrillary acidic protein gene is found in a patient with Alexander disease."}, {"pubmed": 19647039, "text": "GFAP-delta may be a useful diagnostic marker for the evaluation of functional cataplasia or proliferation of astrocytic tumor."}, {"pubmed": 19663312, "text": "Determination of relative levels of MBP and GFAP mRNAs may be useful for glial tumors recognition."}, {"pubmed": 19668151, "text": "GFAP is a potential marker for tumors with cartilaginous differentiation."}, {"pubmed": 19686046, "text": "Results identified glial fibrillary acidic protein that showed elevated levels of protein carbonyls in inferior parietal lobule (IPL) from subjects with early stage-Alzheimer's disease."}, {"pubmed": 19888461, "text": "GFAP+1 expressing astrocytes may have a specific role in Alzheimer's disease"}, {"pubmed": 20048155, "text": "Data demonstrate that withaferin A covalently binds soluble recombinant tetrameric human GFAP at cysteine 294."}, {"pubmed": 20121722, "text": "show that GFAP-delta is expressed in an astrocytic subpopulation in the subventricular zone, the rostral migratory stream and the olfactory bulb"}, {"pubmed": 20471030, "text": "This protein has been found differentially expressed in thalami from patients with schizophrenia."}, {"pubmed": 20625342, "text": "To determine whether serum GFAP levels correlate with functional outcome in traumatic brain injury. Serum GFAP concentration may have prognostic value after TBI in children."}, {"pubmed": 20721574, "text": "[review] In recent years, following the discovery of GFAP mutation as the causative event in Alexander (AxD) disease, the rate at which newly diagnosed AxD cases have been reported has greatly increased."}, {"pubmed": 20849398, "text": "This study presented some Japaneses adult-onset Alexander disease with Glial fibrillary acidic protein mutations."}, {"pubmed": 20886841, "text": "Data show that NDRG2 and GFAP had an increased number of phosphospectra in FTLD."}, {"pubmed": 20942581, "text": "The intensity of GFAP staining was negatively correlated with time from the onset of hematoma formation after intracerebral hemorrhage"}, {"pubmed": 21075782, "text": "Epigenetic silencing of the GFAP gene through DNA methylation of its promoter region may be one mechanism by which GFAP is downregulated in gliomas."}, {"pubmed": 21079180, "text": "Outcome prediction after traumatic brain injury can be improved with determination of serum levels of GFAP and S100 calcium-binding protein beta chain (S100B) at the time of hospital admission."}, {"pubmed": 21197541, "text": "GFAP is a potential biomarker for multiple sclerosis progression"}, {"pubmed": 21368691, "text": "The relationship of clinical outcome with cerebrospinal fluid neuron-specific enolase (NSE), S100B and glial fibrillary acidic protein (GFAP) levels in patients with severe traumatic brain injury was investigated"}, {"pubmed": 21702960, "text": "GFAP levels are higher in traumatic brain injury patients with mass lesions than in those with diffuse injury."}, {"pubmed": 21756903, "text": "Some mutations in the C-terminus of GFAP correlate with caspase 3 cleavage and the loss of cell viability, suggesting that these could be contributory factors in the development of Alexander disease."}, {"pubmed": 21779366, "text": "Interplay between SIN3A and STAT3 mediates chromatin conformational changes and GFAP expression during cellular differentiation.("}, {"pubmed": 21876753, "text": "The aim of this study was to ascertain the extent to which serum GFAP levels can distinguish between an episode of optic neuritis (ON) related to neuromyelitis optica spectrum disease and ON from other causes."}, {"pubmed": 21917775, "text": "Age at onset and the GFAP mutation site are important clinical predictors in Alexander disease, with clear correlations to defined patterns of phenotypic expression."}, {"pubmed": 21976236, "text": "Children who had worse outcomes after traumatic brain injury, or died, have higher GFAP values, but their dynamics are similar over the same period."}, {"pubmed": 21987397, "text": "Mutations in GFAP and behavior of mutant protein in cellular transfection assays was conducted in two families with Alexander disease"}, {"pubmed": 22118268, "text": "GFAP mutations in Alexander disease (Review)"}, {"pubmed": 22206859, "text": "The serum levels of GFAP and neurofilament proteins were significantly higher in the Parkinson's disease group than in the normal group"}, {"pubmed": 22318658, "text": "GFAP-delta immunoreactivity was significantly correlated with spinal cord astrocytoma grade in astrocytomas compared to that in normal control tissues."}, {"pubmed": 22360420, "text": "A protein encoded by this locus was found to be differentially expressed in postmortem brains from patients with atypical frontotemporal lobar degeneration."}, {"pubmed": 22410258, "text": "Serum GFAP levels in a control cohort are not significantly different compared to neuromyelitis optica patients."}, {"pubmed": 22488673, "text": "The findings recommend inclusion of intronic splice site regions in genetic testing for AxD, indicate that alteration of only a small fraction of GFAP can produce disease, and provide caution against tagging intermediate filaments for investigations."}, {"pubmed": 22492246, "text": "High plasma GFAP is associated with high-grade gliomas"}, {"pubmed": 22985558, "text": "The protein and mRNA expressions of GFAP decreased significantly in grade III and IV astrocytoma compared with those in grade II astrocytoma and normal brain tissues."}, {"pubmed": 23321059, "text": "GFAP is a target for QKI in humans but not rodents."}, {"pubmed": 23364391, "text": "GFAP mutations were identified in 95.46% of Chinese children with clinically diagnosed type I AxD"}, {"pubmed": 23371454, "text": "High GFAP levels are associated with infratentorial ependymomas."}, {"pubmed": 23392373, "text": "Serum UCHL1 and GFAP are associated with death or severe brain injury in newborns with hypoxic ischemic encephalopathy."}, {"pubmed": 23418544, "text": "Data indicate that five important proteins, vimentin, gelsolin, alpha 2 HS glycoprotein (AHSG), glial fibrillary acidic protein (GFAP), and alpha1B-glycoprotein (A1BG) were expressed higher in Rheumatoid arthritis (RA) synovial fluid than non-RA samples."}, {"pubmed": 23489259, "text": "GFAP-breakdown products blood levels reliably distinguished severity of injury in traumatic brain injury patients."}, {"pubmed": 23594359, "text": "Immunohistochemistry of synemin in reactive astrocytes and Rosenthal fibers in two patients with Alexander disease. There was an abundance of GFAP-positive Rosenthal fibers and widespread reactive gliosis in the white matter and subpial regions."}, {"pubmed": 23624779, "text": "High plasma-GFAP levels are associated with metastatic myxopapillary ependymoma."}, {"pubmed": 23626774, "text": "Most acute and chronic neurological diseases, including typical stroke mimics, are not associated with detectable GFAP levels in the bloodstream."}, {"pubmed": 23634874, "text": "Our results support the hypothesis that the HDAC6P856S protein variant may be acting synergistically with the GFAP-R430H mutation, conditioning the development of the severe alexander diseases phenotype."}, {"pubmed": 23743246, "text": "This study reveled that glial fibrillary acidic protein gene mutation (D78N) inpatient with Familial adult-onset Alexander disease."}, {"pubmed": 23746601, "text": "We detected significantly higher CSF levels of GFAP in patients with low hcrt-1 levels, of which the majority had a diagnosis of narcolepsy and cataplexy."}, {"pubmed": 23826164, "text": "The expression levels of various hGFAP transgenes at different ages."}, {"pubmed": 23827424, "text": "In CSF, GFAP is increased in children with brain injuries compared to controls."}, {"pubmed": 23845562, "text": "There are significant increases in glial fibrillary acidic protein levels in children undergoing cardiopulmonary bypass for repair of congenital heart disease. The highest values were seen during the re-warming phase."}, {"pubmed": 23903069, "text": "The C/C genotype at rs2070935 of the GFAP promoter in late-onset AxD was associated with an earlier onset and a more rapid progression of ambulatory disability compared with the other genotypes."}, {"pubmed": 23911257, "text": "This study demonistratedt hat Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness"}, {"pubmed": 23991052, "text": "Data indicate that Gfapdelta is expressed in the in developing mouse brain sub-ventricular zones in accordance with the described localization in the developing and adult human brain."}, {"pubmed": 24045243, "text": "We report the case of a child with disease onset at the age of 3 months and a novel mutation in the glial fibrillary acidic protein gene."}, {"pubmed": 24102621, "text": "The findings of this study that caspase-mediated GFAP proteolysis may be a common event in the context of both the GFAP mutation and excess."}, {"pubmed": 24269023, "text": "Its expression is associated with plaque load related astrogliosis in Alzheimer's disease."}, {"pubmed": 24374936, "text": "This stuidy demonistrated that Fibrillary astrocytes are decreased in the subgenual cingulate in schizophrenia."}, {"pubmed": 24505052, "text": "The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning"}, {"pubmed": 24667434, "text": "TBI patients showed an average 3.77 fold increase in anti-GFAP autoantibody levels from early (0-1 days) to late (7-10 days) times post injury."}, {"pubmed": 24749759, "text": "We showed that GFAP is over-expressed and hypophosphorylated in the enteric glial cells of Parkinson's disease patients as compared to healthy subjects"}, {"pubmed": 24755947, "text": "Identification of a novel nonsense mutation in the rod domain of GFAP that is associated with Alexander disease."}, {"pubmed": 25128567, "text": "These data imply that a tight regulation of histone acetylation in astrocytes is essential, because dysregulation of gene expression causes the aggregation of GFAP, a hallmark of human diseases like Alexander's disease."}, {"pubmed": 25139333, "text": "A combined profile of preoperative IGFBP-2, GFAP, and YKL-40 plasma levels could serve as an additional diagnostic tool for patients with inoperable brain lesions suggestive of Glioblastoma multiforme."}, {"pubmed": 25178519, "text": "It could be a clinically relevant marker associated with tumor invasiveness in cerebral astrocytomas."}, {"pubmed": 25341992, "text": "Studied diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury."}, {"pubmed": 25726916, "text": "GFAP, the principal intermediate filament protein of astrocytes, is involved in physiological, but in particular, in pathophysiological functions of astrocytes, the latter ones being connected with astrocyte activation and reactive gliosis. [Review]"}, {"pubmed": 25846779, "text": "GFAP is upregulated following an insult or injury to the brain, additionally making it an indicator of CNS pathology."}, {"pubmed": 25859599, "text": "The data on the changes in expression of GFAP in Alexander disease caused by the primary pathology of astrocytes are presented."}, {"pubmed": 25904356, "text": "There was an absence of GFAP in astrocytes during early fetal spinal cord development until 9 months of gestation , and the appearance of GFAP-positive reactivity was later than that of neurons."}, {"pubmed": 26033239, "text": "We found downregulation of GFAP mRNA and protein in the mediodorsal thalamus and caudate nucleus of depressed suicides compared with controls, whereas GFAP expression in other brain regions was similar between groups. Furthermore, a regional comparison including all samples revealed that GFAP expression in both subcortical regions was, on average, between 11- and 15-fold greater than in cerebellum and neocortex."}, {"pubmed": 26081945, "text": "GFAP peaks early during haemorrhagic brain lesions (at significantly higher levels), and late in ischaemic events, whereas antibodies against NR2 RNMDA have significantly higher levels during ischemic stroke at all time-points."}, {"pubmed": 26135781, "text": "No difference in cord blood concentration found between hypoxic-ischemic encephalopathy neonates and controls"}, {"pubmed": 26208460, "text": "Neither duplications nor deletions of GFAP were found, suggesting that GFAP coding-region rearrangements may not be involved in Alexander disease or Alexanderrelated leukoencephalopathies."}, {"pubmed": 26279003, "text": "The data suggest that human vitreous body GFAP is a protein biomarker for glial activation in response to retinal pathologies."}, {"pubmed": 26485083, "text": "The levels of GFAP in Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration patients were significantly higher than those in the healthy control subjects."}, {"pubmed": 26526443, "text": "This study demonstrated that GFAP as a promising biomarker to distinguish ischemic stroke from intracerebral hemorrhage."}, {"pubmed": 26547005, "text": "GFAP is significantly associated with outcome, but it does not add predictive power to commonly used prognostic variables in a population of patients with TBI of varying severities."}, {"pubmed": 26742791, "text": "This study demonistrated that the density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder"}, {"pubmed": 26786018, "text": "Overall, glial fibrillary acidic protein reflected no evidence for significant peripartum brain injury in neonates with congenital heart defects, but there was a trend for elevation by postnatal day 4 in neonates with left heart obstruction."}, {"pubmed": 27016413, "text": "Results show that the positive rates and expression levels of nestin, tyrosine hydroxylase (TH), GFAP and IL-17 were significantly decreased while Foxp3 and the ratio of Foxp3/IL-17 were statistically elevated in BM of AML patients."}, {"pubmed": 27018834, "text": "This study demonstrated that GFAP exhibited distinct temporal profiles over the course of 7 days in patient with traumatic brain injury."}, {"pubmed": 27097671, "text": "serum levels of GFAP were significantly lower in autism spectrum disorders than controls"}, {"pubmed": 27141937, "text": "the exchange of GFP-GFAPdelta was significantly slower than the exchange of GFP-GFAPalpha with the intermediate filament-network."}, {"pubmed": 27312416, "text": "GFAP, along with tau and AmyloidBeta42, were increased in plasma up to 90 days after traumatic brain injury compared with controls."}, {"pubmed": 27319802, "text": "The authors observed higher serum levels of GFAP and UCH-L1 in brain-injured children compared with controls and also demonstrated a step-wise increase of biomarker concentrations over the continuum of severity from mild to severe traumatic brain injury.  Serum UCH-L1 and GFAP concentrations also strongly predicted poor outcome."}, {"pubmed": 27488116, "text": "High GFAP expression is associated with retinoblastoma."}, {"pubmed": 27609520, "text": "Tat expression or GFAP expression led to formation of GFAP aggregates and induction of unfolded protein response (UPR) and endoplasmic reticulum (ER) stress in astrocytes."}, {"pubmed": 27951536, "text": "GFAP levels >0.29 ng/ml were seen only in intracerebral hemorrhage, thus confirming the diagnosis of ICH during prehospital care."}, {"pubmed": 28063220, "text": "GFAP is specifically expressed in the auricular chondrocytes, and assumes a pivotal role in resistance against mechanical stress."}, {"pubmed": 28088366, "text": "e data indicates that serum GFAP levels may be associated with severity of autism spectrum disorders among Chinese children."}, {"pubmed": 28419863, "text": "Bevacizumab treatment was also associated with structural protein abnormalities, with decreased GFAP and vimentin content and upregulated GFAP and vimentin mRNA expression."}, {"pubmed": 28546444, "text": "These results indicate that autoantibodies against GFAP could serve as a predictive marker for the development of overt autoimmune diabetes."}, {"pubmed": 28552414, "text": "Study examined if QKI6B expression can predict the outcome of GFAP, and several oligodendrocyte-related genes, in the prefrontal cortex of brain samples of schizophrenic individuals. QKI6B significantly predicts the expression of GFAP, but does not predict oligodendrocyte-related gene outcome, as previously seen with other QKI isoforms."}, {"pubmed": 28751552, "text": "Higher median plasma GFAP values were documented in intracerebral hemorrhage compared with acute ischemic stroke, stroke mimics, and controls."}, {"pubmed": 28768252, "text": "amniotic fluid -GFAP levels differentiate between myelomeningocele and myeloschisis, and raise interesting questions regarding the clinical significance between the 2 types of defects."}, {"pubmed": 28972406, "text": "This study demonstrated that Concentrations of microparticles expressing GFAP and AQP4 were significantly higher in the traumatic brain injury group compared with healthy controls."}, {"pubmed": 29074065, "text": "Plasma concentration of GFAP demonstrated associations with stroke occurrence in a West African cohort but was not associated with stroke severity or mortality."}, {"pubmed": 29193473, "text": "The features of the neuropathology and immunopathology of GFAP astrocytopathies were perivascular inflammation and loss of astrocytes and neurons"}, {"pubmed": 29196434, "text": "Desmin, Glial Fibrillary Acidic Protein, Vimentin, and Peripherin are type III intermediate filaments that have roles in health and disease [review]"}, {"pubmed": 29308673, "text": "GFAP levels are a novel and complementary biomarker to predict functional outcome 1 year after acute ischemic stroke."}, {"pubmed": 29484801, "text": "serum levels do not increase in diabetic ketoacidosis patients without overt brain injury"}, {"pubmed": 29746255, "text": "GFAP rs11558961 was found to be significantly associated with GBM susceptibility. It was predicted to influence microRNA(miR)-139 binding to 3'UTR of GFAP gene"}, {"pubmed": 30070096, "text": "serum level not significantly elevated in newborns at risk for hypoxic ischemic encephalopathy but with normal EEGs"}, {"pubmed": 30126635, "text": "crystal structure of human GFAP spanning the central coiled-coil 1B domain at 2.5A resolution"}, {"pubmed": 30224549, "text": "The GFAP concentration in CSF was significantly increased in genetic and sporadic frontotemporal dementia compared with controls and genetic and sporadic ALS. There was no difference between controls, asymptomatic mutation carriers and genetic ALS groups."}, {"pubmed": 30300267, "text": "CHANGES OF AQUEOUS HUMOR MULLER CELLS' BIOMARKERS IN HUMAN PATIENTS AFFECTED BY DIABETIC MACULAR EDEMA AFTER SUBTHRESHOLD MICROPULSE LASER TREATMENT."}, {"pubmed": 30303809, "text": "GFAP is a promising diagnostic biomarker for ICH diagnosis in the early pre-hospital phase"}, {"pubmed": 30304049, "text": "Post-mortem GFAP serum concentrations correlate with agony time and might therefore be useful for the evaluation of the severity of brain damage in prolonged death. Elevated GFAP serum levels do not indicate a primary cerebral cause of death."}, {"pubmed": 30355500, "text": "Alexander disease-causing mutations in GFAP disrupt intracellular vesicle regulation and impair astrocyte secretion."}, {"pubmed": 30520434, "text": "Spearman's rank correlation analysis and Bonferroni correction were used to compare the values of DKI and the expression levels of GFAP, Topo IIalpha, and MGMT between the 2 groups."}, {"pubmed": 30594925, "text": "Sensitivity and specificity of serum GFAP for Alzheimer's disease versus frontotemporal dementia was 89% and 79% and might be the first blood biomarker in the differential diagnosis of Alzheimer's disease and frontotemporal dementia"}, {"pubmed": 30601636, "text": "The obtained data testify higher specificity and sensitivity of glio-fibrillar acid protein as a biochemical marker of glioblastoma appropriate to be applied in case of primary examination of patients with brain affection."}, {"pubmed": 30801815, "text": "Regulation of GFAP expression in astrocytes is crucial for astrocyte signaling and function."}, {"pubmed": 31004048, "text": "GFAP analysis should be considered in adult-onset neurological presentations with pyramidal and bulbar symptoms, in particular when characteristic findings, such as the tadpole sign, are present in MRI"}, {"pubmed": 31051301, "text": "Median GFAP concentrations were greater in trauma patients with traumatic brain injury on CT compared to subjects without TBI."}, {"pubmed": 31132788, "text": "Placental clearance/synthesis of neurobiomarkers GFAP and UCH-L1 in healthy term neonates and those with moderate-severe neonatal encephalopathy."}, {"pubmed": 31234132, "text": "NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries."}, {"pubmed": 31327295, "text": "Glial fibrillary acidic protein (GFAP) autoimmunity may be a paraneoplastic immune response with a low frequency of tumor in Chinese patients with GFAP astrocytopathy."}, {"pubmed": 31480854, "text": "show that a high GFAP-delta/alpha ratio induces the expression of the dual-specificity phosphatase 4 (DUSP4) in focal adhesions. By focusing on pathways up- and downstream of DUSP4 that are involved in the cell-extracellular matrix interaction, we show that a high GFAP-delta/alpha ratio equips glioma cells to better invade the brain"}, {"pubmed": 31484723, "text": "Alexander disease onset is due to an intrinsic toxicity of the mutant GFAP."}, {"pubmed": 31503390, "text": "A single nucleotide polymorphism (-250 A/C) of the GFAP gene is associated with brain structures and cerebral blood flow."}, {"pubmed": 31642374, "text": "Assessing a Blast-Related Biomarker in an Operational Community: Glial Fibrillary Acidic Protein in Experienced Breachers."}, {"pubmed": 31682229, "text": "Findings indicate selective phosphorylation of glial fibrillary acidic protein (GFAP)-Ser13 in patients who died young, independently of the mutation they carried."}, {"pubmed": 31857507, "text": "level of serum GFAP is significantly increased in sepsis-associated encephalopathy"}, {"pubmed": 31893463, "text": "Glial fibrillary acid protein was elevated after approximately 50% of neonatal cardiac surgeries and was related to cerebral oxygenation and older age at surgery, suggesting potential value as a biomarker for cerebral injury after neonatal cardiac surgery."}, {"pubmed": 32096121, "text": "Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke."}, {"pubmed": 32096416, "text": "Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy."}, {"pubmed": 32126152, "text": "Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform."}, {"pubmed": 32147765, "text": "Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Malignant Glial Tumors."}, {"pubmed": 32278699, "text": "Does the expression of glial fibrillary acid protein (GFAP) stain in glioblastoma tissue have a prognostic impact on survival?"}, {"pubmed": 32303142, "text": "Serum glial fibrillary acidic protein (GFAP)-antibody in idiopathic intracranial hypertension."}, {"pubmed": 32374915, "text": "Recessively-Inherited Adult-Onset Alexander Disease Caused by a Homozygous Mutation in the GFAP Gene."}, {"pubmed": 32417628, "text": "Parkinsonism phenotype in a family with adult onset Alexander disease and a novel mutation of GFAP."}, {"pubmed": 32445783, "text": "Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients."}, {"pubmed": 32804092, "text": "Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration."}, {"pubmed": 32907910, "text": "Discriminative value of glial fibrillar acidic protein (GFAP) as a diagnostic tool in acute stroke. Individual patient data meta-analysis."}, {"pubmed": 32945401, "text": "miR15a inhibits cell apoptosis and inflammation in a temporal lobe epilepsy model by downregulating GFAP."}, {"pubmed": 33027920, "text": "Involvement of the Retinal Pigment Epithelium in the Development of Retinal Lattice Degeneration."}, {"pubmed": 33161932, "text": "Blood Biomarkers Relate to Cognitive Performance Years after Traumatic Brain Injury in Service Members and Veterans."}, {"pubmed": 33479350, "text": "Leakage of astrocyte-derived extracellular vesicles in stress-induced exhaustion disorder: a cross-sectional study."}, {"pubmed": 33556656, "text": "Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI."}, {"pubmed": 33594224, "text": "Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury."}, {"pubmed": 33724534, "text": "Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker."}, {"pubmed": 33734490, "text": "A novel prognosis prediction model, including cytotoxic T lymphocyte-associated antigen-4, ischemia-modified albumin, lipoprotein-associated phospholipase A2, glial fibrillary acidic protein, and homocysteine, for ischemic stroke in the Chinese hypertensive population."}, {"pubmed": 33773595, "text": "Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment."}, {"pubmed": 33845398, "text": "Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer's disease."}, {"pubmed": 33984366, "text": "Neuropsychiatric sequelae of acute carbon monoxide poisoning: The predictive role of neuron specific enolase and glial fibrillary acidic protein."}, {"pubmed": 34021122, "text": "Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression."}, {"pubmed": 34146839, "text": "GFAP variants leading to infantile Alexander disease: Phenotype and genotype analysis of 135 cases and report of a de novo variant."}, {"pubmed": 34196964, "text": "Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer."}, {"pubmed": 34278578, "text": "Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study."}, {"pubmed": 34383905, "text": "Ultra-Early Differential Diagnosis of Acute Cerebral Ischemia and Hemorrhagic Stroke by Measuring the Prehospital Release Rate of GFAP."}, {"pubmed": 34398223, "text": "Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy."}, {"pubmed": 34799461, "text": "Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study."}, {"pubmed": 34828359, "text": "Investigating Markers of the NLRP3 Inflammasome Pathway in Alzheimer's Disease: A Human Post-Mortem Study."}, {"pubmed": 34893073, "text": "Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia."}, {"pubmed": 35013418, "text": "GFAP splice variants fine-tune glioma cell invasion and tumour dynamics by modulating migration persistence."}, {"pubmed": 35085579, "text": "Spatial and temporal immunoreaction of nestin, CD44, collagen IX and GFAP in human retinal Muller cells in the developing fetal eye."}, {"pubmed": 35204724, "text": "Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis."}, {"pubmed": 35511821, "text": "Effects of Alexander disease-associated mutations on the assembly and organization of GFAP intermediate filaments."}, {"pubmed": 35852967, "text": "Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years."}, {"pubmed": 35896928, "text": "Serum glial fibrillary acidic protein (GFAP) predicts outcome after intracerebral and subarachnoid hemorrhage."}, {"pubmed": 35963263, "text": "Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study."}, {"pubmed": 36049341, "text": "Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder."}, {"pubmed": 36120776, "text": "A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias."}, {"pubmed": 36163176, "text": "Area Postrema Syndrome in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Case Series and Literature Review."}, {"pubmed": 36221099, "text": "Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias."}, {"pubmed": 36323711, "text": "An innovative approach for the evaluation of prolonged disorders of consciousness using NF-L and GFAP biomarkers: a pivotal study."}, {"pubmed": 36543540, "text": "Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis."}, {"pubmed": 36621163, "text": "Brain-derived neurotrophic factor, neurofilament light and glial fibrillary acidic protein do not change in response to aerobic training in people with MS-related fatigue - a secondary analysis of a randomized controlled trial."}, {"pubmed": 36655666, "text": "[Clinical features of autoimmune glial fibrillary acidic protein astrocytopathy in children: an analysis of 34 cases]."}, {"pubmed": 36776136, "text": "The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease."}, {"pubmed": 36790588, "text": "Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: a prospective pilot study."}, {"pubmed": 36794762, "text": "The HOPX and BLBP landscape and gliogenic regions in developing human brain."}, {"pubmed": 36806504, "text": "sTREM2 and GFAP Mediated the Association of IGF-1 Signaling Biomarkers with Alzheimer's Disease Pathology."}, {"pubmed": 36959506, "text": "Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study."}, {"pubmed": 37060852, "text": "Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes."}, {"pubmed": 37174709, "text": "GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis."}, {"pubmed": 37338614, "text": "Autoimmune glial fibrillary acidic protein astrocytosis mimicking tuberculous meningitis: a retrospective study."}, {"pubmed": 37392405, "text": "Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study."}, {"pubmed": 37458208, "text": "Epstein-Barr virus: To be a trigger of autoimmune glial fibrillary acidic protein astrocytopathy?"}, {"pubmed": 37495513, "text": "Adult-onset Alexander disease with unusual inflammatory features and a novel GFAP mutation in two patients."}, {"pubmed": 37530894, "text": "Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study."}, {"pubmed": 37572437, "text": "Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients."}, {"pubmed": 37573633, "text": "Overlapping Epstein-Barr virus encephalitis and autoimmune glial fibrillary acidic protein astrocytopathy."}, {"pubmed": 37608748, "text": "Plasma beta-synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy."}, {"pubmed": 37690071, "text": "Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression."}, {"pubmed": 37723371, "text": "The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment."}, {"pubmed": 37778613, "text": "Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest."}, {"pubmed": 37981797, "text": "Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy: An Emerging Cause of Meningoencephalomyelitis in Children and Adolescents."}, {"pubmed": 37990643, "text": "Alexander disease genetics: Beyond GFAP exon sequencing?"}, {"pubmed": 38017278, "text": "Serum beta-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke."}, {"pubmed": 38111972, "text": "Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis."}, {"pubmed": 38145319, "text": "Plasma glial fibrillary acidic protein levels correlate with paramagnetic rim lesions in people with radiologically isolated syndrome."}, {"pubmed": 38173149, "text": "Glial Fibrillary Acidic Protein: Diagnostic and Prognostic Role in Psychomotor Development Dynamics in Patients with Congenital Heart Defects after Cardiovascular Surgery."}, {"pubmed": 38339819, "text": "Relationship between increased serum neurofilament light chain and glial fibrillary acidic protein levels with non-motor symptoms in patients with Parkinson's disease."}, {"pubmed": 38782207, "text": "Glial fibrillary acidic protein is pathologically modified in Alexander disease."}], "genomic_pos": {"chr": "17", "end": 44916937, "ensemblgene": "ENSG00000131095", "start": 44903159, "strand": -1}, "genomic_pos_hg19": {"chr": "17", "end": 42994305, "start": 42982376, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0006886", "qualifier": "involved_in", "term": "intracellular protein transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010467", "qualifier": "involved_in", "term": "gene expression"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010625", "qualifier": "involved_in", "term": "positive regulation of Schwann cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010977", "qualifier": "involved_in", "term": "negative regulation of neuron projection development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014002", "qualifier": "involved_in", "term": "astrocyte development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014010", "qualifier": "involved_in", "term": "Schwann cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030198", "qualifier": "involved_in", "term": "extracellular matrix organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0031102", "qualifier": "involved_in", "term": "neuron projection regeneration"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0043254", "pubmed": 20176123, "qualifier": "involved_in", "term": "regulation of protein-containing complex assembly"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045109", "qualifier": "involved_in", "term": "intermediate filament organization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045109", "pubmed": 15732097, "qualifier": "involved_in", "term": "intermediate filament organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051580", "qualifier": "involved_in", "term": "regulation of neurotransmitter uptake"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060020", "qualifier": "involved_in", "term": "Bergmann glial cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060291", "qualifier": "involved_in", "term": "long-term synaptic potentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070779", "qualifier": "involved_in", "term": "D-aspartate import across plasma membrane"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:1904714", "qualifier": "involved_in", "term": "regulation of chaperone-mediated autophagy"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1904714", "qualifier": "involved_in", "term": "regulation of chaperone-mediated autophagy"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:1904714", "pubmed": 20176123, "qualifier": "involved_in", "term": "regulation of chaperone-mediated autophagy"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 12355421, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005764", "qualifier": "colocalizes_with", "term": "lysosome"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005882", "qualifier": "is_active_in", "term": "intermediate filament"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0042995", "qualifier": "is_active_in", "term": "cell projection"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0044297", "qualifier": "located_in", "term": "cell body"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0045111", "qualifier": "located_in", "term": "intermediate filament cytoskeleton"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0097450", "qualifier": "located_in", "term": "astrocyte end-foot"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098574", "qualifier": "located_in", "term": "cytoplasmic side of lysosomal membrane"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0005178", "qualifier": "enables", "term": "integrin binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005200", "qualifier": "enables", "term": "structural constituent of cytoskeleton"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16189514, 17500595, 25416956, 25910212, 26871637, 27229929, 29892012, 31515488, 32296183, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0019900", "qualifier": "enables", "term": "kinase binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [25416956, 25910212, 32296183], "qualifier": "enables", "term": "identical protein binding"}]}, "homologene": {"genes": [[7955, 30646], [9031, 419969], [9544, 712941], [9598, 454741], [9606, 2670], [9615, 480495], [9913, 281189], [10090, 14580], [10116, 24387]], "id": 1554}, "interpro": [{"desc": "Intermediate filament head, DNA-binding domain", "id": "IPR006821", "short_desc": "Intermed_filament_DNA-bd"}, {"desc": "Intermediate filament, rod domain", "id": "IPR039008", "short_desc": "IF_rod_dom"}, {"desc": "Intermediate filament protein, conserved site", "id": "IPR018039", "short_desc": "IF_conserved"}], "ipi": ["IPI00025363", "IPI00383815", "IPI00443478", "IPI00909238"], "map_location": "17q21.31", "name": "glial fibrillary acidic protein", "other_names": "glial fibrillary acidic protein", "pantherdb": {"HGNC": "4235", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "95697", "ortholog_type": "LDO", "panther_family": "PTHR45652", "taxid": 10090, "uniprot_kb": "P03995"}, {"RGD": "2679", "ortholog_type": "LDO", "panther_family": "PTHR45652", "taxid": 10116, "uniprot_kb": "P47819"}, {"Ensembl": "ENSGALG00000000909", "ortholog_type": "LDO", "panther_family": "PTHR45652", "taxid": 9031, "uniprot_kb": "F1NE70"}, {"ZFIN": "ZDB-GENE-990914-3", "ortholog_type": "LDO", "panther_family": "PTHR45652", "taxid": 7955, "uniprot_kb": "Q58EE9"}], "uniprot_kb": "P14136"}, "pathway": {"biocarta": {"id": "prionpathway", "name": "prion pathway"}, "kegg": {"id": "hsa04630", "name": "JAK-STAT signaling pathway - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1236394", "name": "Signaling by ERBB4"}, {"id": "R-HSA-1251985", "name": "Nuclear signaling by ERBB4"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9612973", "name": "Autophagy"}, {"id": "R-HSA-9613829", "name": "Chaperone Mediated Autophagy"}], "wikipathways": [{"id": "WP2064", "name": "Neural Crest Differentiation"}, {"id": "WP2431", "name": "Spinal Cord Injury"}]}, "pdb": "6A9P", "pfam": ["PF00038", "PF04732"], "pharmgkb": "PA28647", "pharos": {"target_id": 4680, "tdl": "Tbio"}, "pir": ["A32936", "T42645"], "prosite": "PS51842", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167720", "relationship": "is"}, {"id": "GNF178626", "relationship": "is"}, {"id": "GNF189532", "relationship": "is"}, {"id": "GNF200438", "relationship": "is"}, {"id": "GNF215884", "relationship": "is"}, {"id": "GNF227137", "relationship": "is"}, {"id": "GNF232481", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF157667", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF046955", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF005785", "relationship": "is"}, {"id": "GNF005786", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF242718", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF103362", "relationship": "is"}, {"id": "GNF143012", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000017.11", "NC_060941.1", "NG_008401.2"], "protein": ["NP_001124491.1", "NP_001229305.1", "NP_001350775.1", "NP_002046.1"], "rna": ["NM_001131019.3", "NM_001242376.3", "NM_001363846.2", "NM_002055.5"], "translation": [{"protein": "NP_001229305.1", "rna": "NM_001242376.3"}, {"protein": "NP_002046.1", "rna": "NM_002055.5"}, {"protein": "NP_001350775.1", "rna": "NM_001363846.2"}, {"protein": "NP_001124491.1", "rna": "NM_001131019.3"}]}, "reporter": {"HG-U133_Plus_2": ["203540_at", "229259_at"], "HG-U95Av2": "40185_at", "HTA-2_0": ["TC17001588.hg.1", "TC17002230.hg.1", "TC17002663.hg.1"], "HuEx-1_0": ["3723220", "3759410"], "HuGene-1_1": "8016128", "HuGene-2_1": "16845777"}, "summary": "This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008].", "symbol": "GFAP", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1415042"}, "unigene": "Hs.514227", "uniprot": {"Swiss-Prot": "P14136", "TrEMBL": ["K7EKD1", "B4DIR1", "A0A1W2PQ25", "A0A1W2PQS4", "K7EPI4", "K7ELP4", "A0A1W2PR46", "K7EKH9", "A0A1W2PPA3", "A0A1W2PPF0", "A0A1X7SCE1", "A0A1W2PS58", "A0A0G2JLI8", "A0A1W2PQU7", "A0A1X7SBR3", "A0A1W2PRT3", "K7EPT8", "A0A1W2PP21", "K7EJK1", "A0A1W2PPL2", "K7EJU1"]}, "wikipedia": {"url_stub": "Glial fibrillary acidic protein"}}